US5166057A
(en)
*
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
US20060019350A1
(en)
*
|
1989-08-28 |
2006-01-26 |
Peter Palese |
Recombinant negative strand RNA virus expression system and vacccines
|
US5854037A
(en)
*
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
US5840520A
(en)
*
|
1989-08-28 |
1998-11-24 |
Aviron |
Recombinant negative strand RNA virus expression systems
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
JPH06501843A
(ja)
*
|
1990-08-14 |
1994-03-03 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
アンチセンスオリゴヌクレオチドによるインフルエンザa型ウイルス,アン・アーバh2n2株の阻害
|
US7374768B1
(en)
*
|
1990-09-25 |
2008-05-20 |
Xenova Research Limited |
Viral vaccines
|
US5837261A
(en)
*
|
1990-09-25 |
1998-11-17 |
Cantab Pharmaceuticals Research Limited |
Viral vaccines
|
US5665362A
(en)
*
|
1990-09-25 |
1997-09-09 |
Cantab Pharmaceuticals Research Limited |
Viral vaccines
|
EP0492920A1
(en)
*
|
1990-12-24 |
1992-07-01 |
Merck & Co. Inc. |
Chimaeric influenza-HIV vaccine
|
CA2084180A1
(en)
*
|
1991-12-11 |
1993-06-12 |
Paul P. Hung |
Expression of specific immunogens using viral antigens
|
CA2118234A1
(en)
*
|
1992-04-14 |
1993-10-28 |
Peter Palese |
Genetically engineered attenuated viruses
|
WO1994013837A1
(en)
*
|
1992-12-07 |
1994-06-23 |
Lionel Resnick |
Method for detecting a virus
|
EP0711340A4
(en)
*
|
1993-06-11 |
1998-02-04 |
Peter M Palese |
HIGH YIELDS OF INFLUENCE VIRUS
|
US7344722B1
(en)
*
|
1993-06-29 |
2008-03-18 |
The Regents Of The University Of Michigan |
Cold-adapted influenza virus
|
WO1995028175A1
(en)
*
|
1994-04-19 |
1995-10-26 |
Thomas Jefferson University |
Viral ribonucleocapsid as an immunological enhancer
|
ATE245199T1
(de)
*
|
1994-05-20 |
2003-08-15 |
Sinai School Medicine |
Behandlung von influenzavirus-infektion unter verwendung von antiviralen acylierung/palmitylierung von hemagglutinin hemmen
|
DE69532369T3
(de)
|
1994-07-18 |
2010-11-04 |
Conzelmann, Karl-Klaus, Prof. Dr. |
Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strange-RNS-Virus
|
US20030054505A1
(en)
*
|
1997-09-26 |
2003-03-20 |
Hong Jin |
Recombinant rsv expression systems and vaccines
|
WO1996010633A1
(en)
*
|
1994-09-30 |
1996-04-11 |
Aviron |
Chimeric influenza virus and electroporation method
|
US5716821A
(en)
*
|
1994-09-30 |
1998-02-10 |
Uab Research Foundation |
Prevention and treatment of respiratory tract disease
|
EP0704533A1
(en)
*
|
1994-09-30 |
1996-04-03 |
Bayer Ag |
An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus
|
WO1996010400A1
(en)
*
|
1994-09-30 |
1996-04-11 |
The Uab Research Foundation |
Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
|
US7465574B2
(en)
*
|
1994-09-30 |
2008-12-16 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
US5597697A
(en)
*
|
1994-09-30 |
1997-01-28 |
Diamond; Paul |
Screening assay for inhibitors and activators of RNA and DNA-dependent nucleic acid polymerases
|
US5756341A
(en)
*
|
1994-11-10 |
1998-05-26 |
Immuno Ag |
Method for controlling the infectivity of viruses
|
US6146873A
(en)
*
|
1994-11-10 |
2000-11-14 |
Baxter Aktiengesellschaft |
Production of orthomyxoviruses in monkey kidney cells using protein-free media
|
US5698433A
(en)
*
|
1994-11-10 |
1997-12-16 |
Immuno Ag |
Method for producing influenza virus and vaccine
|
US5753489A
(en)
*
|
1994-11-10 |
1998-05-19 |
Immuno Ag |
Method for producing viruses and vaccines in serum-free culture
|
DE19503082A1
(de)
*
|
1995-02-01 |
1996-08-08 |
Univ Ludwigs Albert |
Gegenstand und Verfahren zur bevorzugt transienten Expression und möglichen Translation spezifischer RNA im cytoplasmatischen Bereich höherer eukaryontischer Zellen
|
US7153510B1
(en)
*
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
EP0780475B2
(en)
*
|
1995-08-09 |
2006-07-19 |
SCHWEIZ. SERUM- & IMPFINSTITUT BERN |
Process for the production of infectious negative-strand RNA viruses
|
AU7335196A
(en)
|
1995-10-31 |
1997-05-22 |
Dnavec Research Inc. |
(-)-strand rna virus vector having autonomously replicating activity
|
ATE470704T1
(de)
*
|
1995-11-01 |
2010-06-15 |
Dnavec Research Inc |
Rekombinantes sendai-virus
|
ES2109189B1
(es)
*
|
1996-03-14 |
1998-05-16 |
Iberica Cyanamid |
Vectores basados en genomas virales defectivos recombinantes y su empleo en la formulacion de vacunas.
|
CA2253595A1
(en)
*
|
1996-05-01 |
1997-11-06 |
The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services |
Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins
|
US6022863A
(en)
*
|
1996-05-21 |
2000-02-08 |
Yale University |
Regulation of gene expression
|
US5939262A
(en)
|
1996-07-03 |
1999-08-17 |
Ambion, Inc. |
Ribonuclease resistant RNA preparation and utilization
|
US5677124A
(en)
*
|
1996-07-03 |
1997-10-14 |
Ambion, Inc. |
Ribonuclease resistant viral RNA standards
|
EP1860192A1
(en)
|
1996-09-17 |
2007-11-28 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating intracellular diseases
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
US20030125280A1
(en)
*
|
1996-12-03 |
2003-07-03 |
Medical University Of South Carolina |
Tissue specific and target RNA-specific ribozymes as antimicrobial therapeutics against microbial pathogens
|
US6884414B1
(en)
|
1997-04-30 |
2005-04-26 |
Mount Sinai School Of Medicine Of New York University |
Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
|
ES2289782T3
(es)
|
1997-05-07 |
2008-02-01 |
The Cleveland Clinic Foundation |
Clon infeccioso para el virus parainfluenza de tipo 3 humano.
|
DE69838584T2
(de)
|
1997-08-04 |
2008-06-26 |
Cell Genesys, Inc., Foster City |
Enhancer des menschlichen glandulären kallikreingens, vektoren die ihn enthalten und methoden für seine verwendung
|
US6872518B2
(en)
|
1997-09-22 |
2005-03-29 |
University Of Rochester |
Methods for selecting polynucleotides encoding T cell epitopes
|
US6830748B1
(en)
|
1997-09-26 |
2004-12-14 |
Medimmune Vaccines, Inc. |
Recombinant RSV virus expression systems and vaccines
|
CN1263854C
(zh)
|
1997-11-06 |
2006-07-12 |
启龙股份公司 |
奈瑟球菌抗原
|
WO1999036544A2
(en)
|
1998-01-14 |
1999-07-22 |
Chiron S.P.A. |
Neisseria meningitidis antigens
|
US6338954B1
(en)
*
|
1998-02-27 |
2002-01-15 |
Pamgene B.V. |
Method for the non-specific amplification of nucleic acid
|
NZ507195A
(en)
*
|
1998-03-27 |
2003-07-25 |
Cytos Biotechnology Ag |
Inducible alphaviral gene expression system
|
EP1645631B1
(en)
|
1998-05-01 |
2007-10-24 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria antigens and compositions
|
IL140265A0
(en)
*
|
1998-06-12 |
2002-02-10 |
Sinai School Medicine |
Methods and interferon deficient substrates for propagation of viruses
|
WO1999064571A1
(en)
*
|
1998-06-12 |
1999-12-16 |
Mount Sinai School Of Medicine Of The City University Of New York |
Interferon inducing genetically engineered attenuated viruses
|
WO1999067400A1
(en)
*
|
1998-06-24 |
1999-12-29 |
Musc Foundation For Research Development |
Tissue-specific and target rna-specific ribozymes
|
JP2002521461A
(ja)
|
1998-07-29 |
2002-07-16 |
インビトロゲン・コーポレーション |
Rnaウイルスを用いる組換えタンパク質の調節発現
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
US7326542B2
(en)
*
|
1998-12-02 |
2008-02-05 |
Princeton University |
Compositions and methods for regulating bacterial pathogenesis
|
US6720415B2
(en)
*
|
1998-12-02 |
2004-04-13 |
Princeton University |
Compositions and methods for regulating bacterial pathogenesis
|
EP1035209A1
(en)
*
|
1999-03-06 |
2000-09-13 |
ARTEMIS Pharmaceuticals GmbH |
Stable recombinant influenza viruses free of helper viruses
|
US6864235B1
(en)
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6911429B2
(en)
*
|
1999-04-01 |
2005-06-28 |
Transition Therapeutics Inc. |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US8715940B2
(en)
*
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
EP1169480A4
(en)
*
|
1999-04-14 |
2005-02-02 |
Musc Found For Res Dev |
TISSUE-SPECIFIC AND PATHOGENIC TOXIC SUBSTANCES AND RIBOZYMES
|
US6271359B1
(en)
|
1999-04-14 |
2001-08-07 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
WO2000066741A2
(en)
|
1999-04-30 |
2000-11-09 |
Chiron S.P.A. |
Conserved neisserial antigens
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
WO2001009291A1
(en)
*
|
1999-07-30 |
2001-02-08 |
Isis Innovation Limited |
Attenuated influenza virus useful as vaccine
|
PT2275551E
(pt)
|
1999-10-29 |
2015-06-29 |
Novartis Vaccines & Diagnostic |
Péptidos antigénicos de neisseria
|
AU1647501A
(en)
|
1999-12-10 |
2001-06-18 |
Cytos Biotechnology Ag |
Replicon based activation of endogenous genes
|
MXPA02006962A
(es)
|
2000-01-17 |
2002-12-13 |
Chiron Spa |
Vacuna de vesicula de membrana exterior que comprende proteinas de membrana exterior de neisseria meningitidis serogrupo b.
|
US6764685B1
(en)
|
2000-03-21 |
2004-07-20 |
Medimmune Vaccines, Inc. |
Recombinant parainfluenza virus expression systems and vaccines
|
US20030194696A1
(en)
*
|
2000-03-28 |
2003-10-16 |
University Of Rochester |
Methods of producing a library and methods of selecting polynucleotides of interest
|
WO2001072995A2
(en)
*
|
2000-03-28 |
2001-10-04 |
University Of Rochester |
Methods of producing a library and methods of selecting polynucletides
|
AU2001257001A1
(en)
*
|
2000-04-10 |
2001-10-23 |
Mount Sinai School Of Medicine Of New York University |
Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
|
EP1702983A3
(en)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
|
EP1317559B1
(en)
|
2000-04-28 |
2009-01-07 |
St. Jude Children's Research Hospital |
Dna transfection system for the generation of infectious negative strand rna virus
|
IES20010462A2
(en)
*
|
2000-05-12 |
2001-11-14 |
Cyril John Higgins |
Use of the world wide web
|
EP1950297A2
(en)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
|
EP1303613A2
(en)
*
|
2000-06-23 |
2003-04-23 |
American Cyanamid Company |
Rescue of canine distemper virus from cdna
|
US20020012982A1
(en)
*
|
2000-07-13 |
2002-01-31 |
Invitrogen Corporation |
Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
|
US7691821B2
(en)
|
2001-09-19 |
2010-04-06 |
University Of South Florida |
Inhibition of SHIP to enhance stem cell harvest and transplantation
|
US20020165192A1
(en)
*
|
2000-09-19 |
2002-11-07 |
Kerr William G. |
Control of NK cell function and survival by modulation of ship activity
|
CA2881568C
(en)
|
2000-10-27 |
2019-09-24 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from streptococcus groups a & b
|
AU2875602A
(en)
*
|
2000-12-07 |
2002-06-18 |
Univ Pennsylvania |
Selection of catalytic nucleic acids targeted to infectious agents
|
WO2002098457A2
(en)
*
|
2001-01-17 |
2002-12-12 |
Thomas Jefferson University |
Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
|
KR101105984B1
(ko)
*
|
2001-01-19 |
2012-01-18 |
비로노바티브 비.브이. |
감응성 포유류에서 호흡계 질환을 유발하는 바이러스
|
US20030232061A1
(en)
*
|
2001-10-18 |
2003-12-18 |
Fouchier Ronaldus Adrianus Maria |
Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
|
US8715922B2
(en)
*
|
2001-01-19 |
2014-05-06 |
ViroNovative |
Virus causing respiratory tract illness in susceptible mammals
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
US6723559B2
(en)
|
2001-04-17 |
2004-04-20 |
Institute Pasteur |
Recombinant segmented negative strand virus containing bicistronic vrna segment with a duplication of its 3′ noncoding flanking sequence, and vaccines and therapeutic compositions containing the same
|
GB0123276D0
(en)
|
2001-09-27 |
2001-11-21 |
Imp College Innovations Ltd |
Uses of agents that bind immune-system components
|
EP2335724A1
(en)
|
2001-12-12 |
2011-06-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Immunisation against chlamydia trachomatis
|
WO2003104428A2
(en)
|
2002-01-21 |
2003-12-18 |
Vaccinex, Inc. |
Gene differentially expressed in breast and bladder cancer and encoded polypeptides
|
US7820435B2
(en)
*
|
2002-02-06 |
2010-10-26 |
Expression Technologies Inc. |
De novo synthesized plasmid, methods of making and use thereof
|
KR101011410B1
(ko)
*
|
2002-02-13 |
2011-01-28 |
위스콘신 얼럼나이 리서어치 화운데이션 |
인플루엔자 바이러스 벡터의 패키징을 위한 신호
|
EP3009507B1
(en)
*
|
2002-02-13 |
2020-06-24 |
Wisconsin Alumini Research Foundation |
Signal for packaging of influenza virus vectors
|
US8709442B2
(en)
*
|
2002-02-21 |
2014-04-29 |
Icahn School Of Medicine At Mount Sinai |
Recombinant negative strand virus RNA expression systems and vaccines
|
CN101098958A
(zh)
|
2002-02-21 |
2008-01-02 |
免疫医疗疫苗公司 |
间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
US20050158342A1
(en)
|
2003-12-23 |
2005-07-21 |
Medimmune, Inc. |
Multi plasmid system for the production of influenza virus
|
CN103540568A
(zh)
|
2002-04-26 |
2014-01-29 |
米迪缪尼有限公司 |
制备流感病毒的多质粒系统
|
EP1534327A4
(en)
*
|
2002-07-25 |
2006-08-23 |
Medimmune Inc |
METHODS OF TREATING AND PREVENTING RSV, HMPV, AND PIV USING ANTI-RSV, ANTI-MPVH, ANTI-PIV ANTIBODIES
|
EP1572108A4
(en)
*
|
2002-09-27 |
2008-09-17 |
Medimmune Vaccines Inc |
FUNCTIONAL MUTATIONS OF RSV (RESPIRATORY SYNCYTIAL VIRUS)
|
US20070224124A1
(en)
*
|
2002-09-30 |
2007-09-27 |
University Of South Florida |
Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein
|
WO2004046177A2
(en)
|
2002-11-15 |
2004-06-03 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
EP2368578A1
(en)
|
2003-01-09 |
2011-09-28 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
EP2494986A1
(en)
|
2003-04-25 |
2012-09-05 |
MedImmune Vaccines, Inc. |
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
|
WO2005027825A2
(en)
*
|
2003-04-25 |
2005-03-31 |
Medimmune Vaccines, Inc. |
Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
|
MX342639B
(es)
*
|
2003-05-28 |
2016-10-07 |
Wisconsin Alumni Res Found |
Virus de la influenza recombinantes de alta titulacion para vacunas y terapia genica.
|
CA2816222A1
(en)
*
|
2003-06-16 |
2005-03-03 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
WO2005019449A2
(en)
*
|
2003-07-03 |
2005-03-03 |
Board Of Trustees Operating Michigan State University |
Expression of a recombinant transgene
|
EP2216415B2
(en)
*
|
2003-08-01 |
2017-01-04 |
Life Technologies Corporation |
Methods for preparing short RNA molecules
|
US7807646B1
(en)
*
|
2003-11-20 |
2010-10-05 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
US7763592B1
(en)
|
2003-11-20 |
2010-07-27 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
CA2559371C
(en)
|
2004-03-09 |
2014-07-08 |
Chiron Corporation |
Influenza virus vaccines
|
KR101222281B1
(ko)
|
2004-03-29 |
2013-01-28 |
가르파마 컴퍼니 리미티드 |
신규 갈렉틴 9 개변체 단백질 및 그 용도
|
WO2005116258A2
(en)
|
2004-05-25 |
2005-12-08 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase varians
|
WO2006083286A2
(en)
|
2004-06-01 |
2006-08-10 |
Mount Sinai School Of Medicine Of New York University |
Genetically engineered swine influenza virus and uses thereof
|
MX2007005719A
(es)
*
|
2004-11-11 |
2007-10-04 |
Univ Erasmus Medical Ct |
Particulas de virus de la influenza defectuosas.
|
JP2008520248A
(ja)
|
2004-11-19 |
2008-06-19 |
ウィスコンシン・アラムナイ・リサーチ・ファウンデイション |
タンデム転写ユニットを有する組換えインフルエンザベクター
|
AU2011204881B2
(en)
*
|
2004-12-24 |
2012-04-19 |
Abbott Biologicals B.V. |
Rescue of influenza virus
|
CN101379183B
(zh)
*
|
2004-12-24 |
2013-07-03 |
雅培生物学有限责任公司 |
流感病毒的拯救
|
WO2006088481A2
(en)
*
|
2005-02-15 |
2006-08-24 |
Mount Sinai School Of Medicine Of New York University |
Genetically engineered equine influenza virus and uses thereof
|
CA2600730C
(en)
|
2005-03-08 |
2014-11-25 |
Medimmune, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
JP2008537482A
(ja)
*
|
2005-03-10 |
2008-09-18 |
メッドイミューン バクシーンズ,インコーポレイティド |
メタニューモウイルス株、およびワクチン製剤におけるその使用および抗原配列発現用ベクターとしてのその使用、ならびにウイルスの増殖法
|
CA2603940A1
(en)
*
|
2005-04-08 |
2006-10-19 |
Nancy Ulbrandt |
Antibodies against mammalian metapneumovirus
|
WO2006113665A2
(en)
|
2005-04-15 |
2006-10-26 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
HUE029465T2
(en)
|
2005-08-10 |
2017-02-28 |
Macrogenics Inc |
Identification and preparation of antibodies with variant fc regions and methods for their use
|
WO2007061969A2
(en)
*
|
2005-11-18 |
2007-05-31 |
Rutgers, The State University |
Vaccines against influenza a and influenza b
|
ES2668018T3
(es)
|
2005-12-02 |
2018-05-16 |
Icahn School Of Medicine At Mount Sinai |
Virus quiméricos de la enfermedad de Newcastle que presentan proteínas de superficie no naturales y sus usos
|
EP2010557B1
(en)
|
2006-03-31 |
2014-02-26 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
MX2008013388A
(es)
|
2006-04-19 |
2009-03-02 |
Medimmune Llc |
Metodos y composiciones para expresar arn viral en sentido negativo en celulas caninas.
|
EP2035035A2
(en)
|
2006-06-09 |
2009-03-18 |
Novartis AG |
Immunogenic compositions for streptococcus agalactiae
|
US7507411B2
(en)
*
|
2006-06-23 |
2009-03-24 |
University Of Saskatchewan |
Attenuated influenza NS1 variants
|
US7601356B2
(en)
*
|
2006-07-21 |
2009-10-13 |
Medimmune, Llc |
Methods and compositions for increasing replication capacity of an influenza virus
|
CA2659267C
(en)
*
|
2006-08-09 |
2016-12-13 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
WO2008105931A2
(en)
|
2006-09-15 |
2008-09-04 |
Medimmune Vaccines, Inc. |
Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
|
US20090098529A1
(en)
|
2006-10-16 |
2009-04-16 |
Nanhai Chen |
Methods for attenuating virus strains for diagnostic and therapeutic uses
|
WO2008147496A2
(en)
*
|
2007-05-04 |
2008-12-04 |
Warf - Wisconsin Alumni Research Foundation |
Neuraminidase-deficient live influenza vaccines
|
ES2523587T3
(es)
|
2007-06-18 |
2014-11-27 |
Medimmune, Llc |
Virus influenza B que tienen alteraciones en el polipéptido hemaglutinina
|
US9474798B2
(en)
|
2007-06-18 |
2016-10-25 |
Wisconsin Alumni Research Foundation |
Influenza M2 protein mutant viruses as live influenza attenuated vaccines
|
CN101821288A
(zh)
|
2007-06-21 |
2010-09-01 |
宏观基因有限公司 |
共价双抗体及其用途
|
US20090186050A1
(en)
*
|
2007-11-16 |
2009-07-23 |
Fouchier Ron A M |
Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
|
EP2574344A1
(en)
*
|
2008-07-11 |
2013-04-03 |
MedImmune, LLC |
Influenza hemagglutinin and neuraminidase variants
|
WO2010036774A1
(en)
|
2008-09-24 |
2010-04-01 |
Medimmune, Llc |
Methods for purification of viruses
|
SG172254A1
(en)
|
2008-12-19 |
2011-07-28 |
Macrogenics Inc |
Covalent diabodies and uses thereof
|
ES2550179T3
(es)
|
2009-02-05 |
2015-11-05 |
Icahn School Of Medicine At Mount Sinai |
Virus quiméricos de la enfermedad de Newcastle y usos de los mismos
|
SG2014010185A
(en)
|
2009-02-12 |
2014-06-27 |
Medimmune Llc |
Influenza hemagglutinin and neuraminidase variants
|
JP2012521786A
(ja)
|
2009-03-30 |
2012-09-20 |
モウント シナイ スクール オフ メディシネ |
インフルエンザウイルスワクチン及びその使用
|
US9217157B2
(en)
|
2009-07-27 |
2015-12-22 |
Icahn School Of Medicine At Mount Sinai |
Recombinant influenza viruses and uses thereof
|
EP2459585A1
(en)
|
2009-07-30 |
2012-06-06 |
Mount Sinai School of Medicine |
Influenza viruses and uses thereof
|
ES2672121T3
(es)
|
2009-10-07 |
2018-06-12 |
Macrogenics, Inc. |
Polipéptidos que contienen región Fc que presentan una función efectora mejorada debido a alteraciones del grado de fucosilación, y métodos para su uso
|
JP2013507990A
(ja)
|
2009-10-26 |
2013-03-07 |
ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション |
ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
EP3900740A1
(en)
|
2010-03-30 |
2021-10-27 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
US20130209406A1
(en)
*
|
2010-06-06 |
2013-08-15 |
Benjamin R. tenOever |
Recombinant rna viruses and uses thereof
|
EP2601216B1
(en)
|
2010-08-02 |
2018-01-03 |
MacroGenics, Inc. |
Covalent diabodies and uses thereof
|
KR102030531B1
(ko)
|
2011-05-21 |
2019-10-10 |
마크로제닉스, 인크. |
탈면역화된 혈청-결합 도메인 및 혈청 반감기를 연장하기 위한 그것의 용도
|
US20130189303A1
(en)
|
2011-08-02 |
2013-07-25 |
Yan Zhou |
Recombinant swine influenza virus and uses thereof
|
WO2013032942A1
(en)
|
2011-08-26 |
2013-03-07 |
Yoshihiro Kawaoka |
Influenza viruses with mutant pb2 gene segment as live attenuated vaccines
|
CN104185476A
(zh)
|
2011-09-20 |
2014-12-03 |
西奈山医学院 |
流感病毒疫苗及其应用
|
US9017694B2
(en)
|
2011-10-07 |
2015-04-28 |
Medimmune, Llc |
Swine influenza hemagglutinin variants
|
WO2014099931A1
(en)
|
2012-12-18 |
2014-06-26 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccines and uses thereof
|
KR102222157B1
(ko)
|
2013-03-14 |
2021-03-03 |
이칸 스쿨 오브 메디슨 엣 마운트 시나이 |
뉴캐슬병 바이러스 및 이의 용도
|
WO2014159960A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
WO2015003003A1
(en)
|
2013-07-01 |
2015-01-08 |
The Research Foundation For The State University Of New York |
Ship inhibition to combat obesity
|
US9950057B2
(en)
|
2013-07-15 |
2018-04-24 |
Wisconsin Alumni Research Foundation (Warf) |
High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs
|
CN107073099B
(zh)
|
2014-02-27 |
2022-09-27 |
默沙东公司 |
用于治疗癌症的联合方法
|
WO2015200070A1
(en)
|
2014-06-17 |
2015-12-30 |
The Research Foundation For The State University Of New York |
Ship inhibition to induce expression of granulocyte colony stimulating factor in a subject
|
WO2015196150A2
(en)
|
2014-06-20 |
2015-12-23 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
AU2015345579B2
(en)
*
|
2014-11-13 |
2019-02-21 |
Versitech Limited |
Live attenuated vaccines for influenza viruses
|
EP3247389A4
(en)
|
2015-01-23 |
2019-10-30 |
Icahn School of Medicine at Mount Sinai |
INFLUENZAVIRUSSCHUTZIMPFPLÄNE
|
EP3261664A1
(en)
|
2015-02-26 |
2018-01-03 |
Boehringer Ingelheim Vetmedica GmbH |
Bivalent swine influenza virus vaccine
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
US9890363B2
(en)
|
2015-07-06 |
2018-02-13 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication for vaccine development
|
EP3337504A1
(en)
|
2015-08-20 |
2018-06-27 |
University of Rochester |
Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
|
WO2017031401A2
(en)
|
2015-08-20 |
2017-02-23 |
University Of Rochester |
Ns1 truncated virus for the development of canine influenza vaccines
|
US10548966B2
(en)
|
2015-08-20 |
2020-02-04 |
University Of Rochester |
Single-cycle virus for the development of canine influenza vaccines
|
WO2017040203A1
(en)
|
2015-08-28 |
2017-03-09 |
Yoshihiro Kawaoka |
Generation of infectious influenza viruses from virus-like particles
|
JP2019510481A
(ja)
|
2016-02-19 |
2019-04-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ワクチン開発のための改善されたb型インフルエンザウイルス複製
|
US10857224B2
(en)
|
2016-06-03 |
2020-12-08 |
University Of Rochester |
Equine influenza virus live attenuated vaccines
|
WO2017218624A1
(en)
|
2016-06-15 |
2017-12-21 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus hemagglutinin proteins and uses thereof
|
CA3058652A1
(en)
|
2017-04-07 |
2018-10-11 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza b virus neuraminidase antibodies and uses thereof
|
JOP20190256A1
(ar)
|
2017-05-12 |
2019-10-28 |
Icahn School Med Mount Sinai |
فيروسات داء نيوكاسل واستخداماتها
|
AR114410A1
(es)
|
2018-02-27 |
2020-09-02 |
Univ Rochester |
Vacuna multivalente contra influenza viva atenuada para prevenir y controlar el virus influenza equino (vie) en caballos
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
EP3914295A2
(en)
|
2019-01-23 |
2021-12-01 |
Yoshihiro Kawaoka |
Mutations that confer genetic stability to additional genes in influenza viruses
|
JP2022522112A
(ja)
|
2019-02-08 |
2022-04-14 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ヒト化細胞系
|
AR118202A1
(es)
|
2019-02-27 |
2021-09-22 |
Univ Rochester |
Vacuna multivalente contra la influenza de virus vivos atenuados para la prevención y el control del virus de la influenza equina (eiv) en caballos
|
WO2020223699A1
(en)
|
2019-05-01 |
2020-11-05 |
Wisconsin Alumni Research Foundation (Warf) |
Improved influenza virus replication for vaccine development
|
WO2021041624A2
(en)
|
2019-08-27 |
2021-03-04 |
Yoshihiro Kawaoka |
Recombinant influenza viruses with stabilized ha for replication in eggs
|